Caris Life Sciences (NASDAQ:CAI) Now Covered by Analysts at Piper Sandler
Stock analysts at Piper Sandler started coverage on shares of Caris Life Sciences (NASDAQ:CAI – Get Free Report) in a research note issued on Friday,Benzinga reports. The brokerage set a “neutral” rating and a $21.00 price target on the stock. Piper Sandler’s price objective suggests a potential upside of 9.38% from the stock’s current price. […]
10 Apr 12:12 · The Markets Daily